Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiamen Amoipharm is a technology-driven pharmaceutical company based in Xiamen, China, specializing in the research, development, and production of high-quality pharmaceutical intermediates and fine chemicals. The company provides a wide range of services including custom synthesis, process optimization, and the supply of novel building blocks for drug discovery. Amoipharm serves global pharmaceutical and biotech companies, leveraging its expertise in medicinal chemistry to accelerate drug development timelines. Their product catalog features diverse chemical scaffolds, including heterocyclic compounds and chiral intermediates, supporting research from lead optimization to clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiamen Amoipharm.